505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA
Similar to 505(b)(2)
AAP - American Academy of PediatricsAAPHP - American Association of Public Health Physicians
AAPM - American Association of Physicists in Medicine
AAR - After Action Review
AARP - American Association of Retired Persons
AAS - Acute Abdominal Series
AASRP - American Association of Small Ruminant Practitioners
View all in FDA